World Conference on Oncology, Liquid Biopsy & Biomarkers

Important dates

1. 1 Nov

   Abstract / full paper deadline

   Passed

2. 28 Nov

   Conference

   Birmingham, UK

All deadlines are as published by the organizer. Check the official website for the time zone.

About this conference

The key intention of ICOLBB is to provide opportunity for the global participants to share their ideas and experience in person with their peers expected to join from different parts on the world. In addition this gathering will help the delegates to establish research or business relations as well as to find international linkage for future collaborations in their career path. We hope that ICOLBB outcome will lead to significant contributions to the knowledge base in these up-to-date scientific fields in scope.

Topics and scope

• Allergo Oncology
• Anticancer Drug Discovery
• Breast cancer
• Cancer Biomarkers
• Cancer Chemotherapy
• Cancer Epidemiology and Prevention
• Cancer Nursing and Integrative Medicine
• Cancer Related Policy and Public Health
• Chemotherapeutic agents
• Chemotherapy and radiotherapy
• Diagnosis and Prognosis of Cancers
• End of life care
• Endocrine tumors
• Etiology of Cancer
• Gastrointestinal cancer
• General oncologic issues
• Genitourinary cancer
• Gynecologic oncology
• Head and neck cancer
• Hormone manipulation
• Immunohistochemistry
• Innovative Technologies in Cancer Research
• Interventional oncology
• Leukemia
• Lung cancer
• Lymphoma
• Mathematical Models in Cancer
• Medical Research on Solid Tumors
• Miscellaneous tumors
• Monoclonal antibody treatment
• Myeloproliferative Diseases
• Nanoscience in oncology
• Neurooncology
• Ocular oncology
• Oncology and biochemistry
• Oncology and biophysics
• Oncology: Diagnosis
• Oncology: Ethical Issues
• Oncology: Therapy
• Pain relief
• Palliative care
• Pediatric oncology
• Plasma cell disorders
• Prostate cancer
• Radiation oncology
• Radiation therapy
• Skin cancer
• Soft tissue and bone tumors
• Surgical oncology
• Translational Oncology
• Tumors immunocompromised host
• Advance Biomarker Research
• Advanced Approaches and Techniques in Biomarker Discover
• Big Data and Precision Medicine
• Biomarkers and Diagnostics, Liquid Biopsy, Imaging, Biochip/Microarray Technologies, Advancements in Technologies
• Biomarkers Imaging and Dynamics
• Biomarkers in Clinical Research
• Biomarkers in Drug Discovery and Development
• Biomarker Validation and Qualification
• Biomedical Informatics
• Cancer Biomarkers
• Cardiac Biomarkers
• Challenges in Identifying Disease Signatures
• Clinical and Translational Biomarkers
• Companion Diagnostics
• Computational Biomarkers
• Controlling Outburst of Mutations
• Data Solutions in Clinical Genomics
• Developing New Nanomedicines for Precision Medicine
• Disease Biomarkers for Precision Medicine
• Drug Discovery and Development
• Drug Target Discovery and Integration with Individualized Therapy, Integration of Diagnosis with Therapy (Theragnosis)
• Emerging Opportunities in Personalized Medicine, Cutting-edge New Strategies and Solutions
• Genetics Informed Personalized Immunotherapy
• Genomic Biomarkers
• Genomic Evaluation by Personalized Studies
• Human Genome Variation
• Integrated Genomics and Therapy
• Integrating Big Data (Genome Data, Pharmacogenomics, Therapeutic Applications of Genome Editing, Genetic Analysis in Clinical Trials Methodology)
• Machine Learning for Computational Genomics and Precision Medicine
• Machine Learning in Bioinformatics
• Machine Learning in Genomic Medicine
• Machine Learning in Genomics
• Machine Learning in Genomics and Precision Medicine
• Metagenomics and Comparative Genomics
• Neuro and Immuno Biomarkers
• Personalized Immunotherapy
• Personalized Therapies (Cancer, Immunology, Infectious Diseases, Clinical Case Studies)
• Personalized Therapy in Cancer
• Pharmacogenomics
• Precision, Personalized and Translational Medicine
• Precision Medicine: Tools, Techniques, and Strategies
• Precision Medicine and Genomics
• Precision Medicine and Novel Technology
• Precision Medicine for Cancer, Infectious and Auto-immune Diseases
• Precision Medicine in the Clinic Research
• Prognostic and Predictive Biomarker Research
• Stem Cell and Cell Therapy in Human Diseases
• The Reliability and Challenges of Precision Medicinee
• Tumor Metabolism and Therapy
•  
•  

Call for papers

The call for papers closed on 1 November 2026. For other conferences, see open calls for papers in this field.